chrX-108733023-G-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001379150.1(IRS4):ā€‹c.3322C>Gā€‹(p.Leu1108Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 1,209,801 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 18 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000071 ( 0 hom., 4 hem., cov: 23)
Exomes š‘“: 0.000034 ( 0 hom. 14 hem. )

Consequence

IRS4
NM_001379150.1 missense

Scores

6
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.87
Variant links:
Genes affected
IRS4 (HGNC:6128): (insulin receptor substrate 4) IRS4 encodes the insulin receptor substrate 4, a cytoplasmic protein that contains many potential tyrosine and serine/threonine phosphorylation sites. Tyrosine-phosphorylated IRS4 protein has been shown to associate with cytoplasmic signalling molecules that contain SH2 domains. The IRS4 protein is phosphorylated by the insulin receptor tyrosine kinase upon receptor stimulation.. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01564607).
BS2
High Hemizygotes in GnomAd4 at 4 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
IRS4NM_001379150.1 linkuse as main transcriptc.3322C>G p.Leu1108Val missense_variant 1/2 ENST00000372129.4
IRS4NM_003604.2 linkuse as main transcriptc.3322C>G p.Leu1108Val missense_variant 1/1
IRS4XM_011531061.2 linkuse as main transcriptc.3322C>G p.Leu1108Val missense_variant 1/3
IRS4XM_006724713.4 linkuse as main transcriptc.3322C>G p.Leu1108Val missense_variant 1/2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
IRS4ENST00000372129.4 linkuse as main transcriptc.3322C>G p.Leu1108Val missense_variant 1/2 NM_001379150.1 A2
IRS4ENST00000564206.2 linkuse as main transcriptc.3322C>G p.Leu1108Val missense_variant 1/1 P5

Frequencies

GnomAD3 genomes
AF:
0.0000714
AC:
8
AN:
112014
Hom.:
0
Cov.:
23
AF XY:
0.000117
AC XY:
4
AN XY:
34184
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000941
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00196
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000121
AC:
22
AN:
182452
Hom.:
0
AF XY:
0.0000894
AC XY:
6
AN XY:
67096
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00159
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000337
AC:
37
AN:
1097735
Hom.:
0
Cov.:
31
AF XY:
0.0000386
AC XY:
14
AN XY:
363139
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00119
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000119
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000714
AC:
8
AN:
112066
Hom.:
0
Cov.:
23
AF XY:
0.000117
AC XY:
4
AN XY:
34246
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000940
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00197
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000718
ExAC
AF:
0.0000824
AC:
10
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 14, 2023The c.3322C>G (p.L1108V) alteration is located in exon 1 (coding exon 1) of the IRS4 gene. This alteration results from a C to G substitution at nucleotide position 3322, causing the leucine (L) at amino acid position 1108 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
T
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.51
T
M_CAP
Uncertain
0.23
D
MetaRNN
Benign
0.016
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-0.070
N
REVEL
Benign
0.060
Sift
Uncertain
0.023
D
Sift4G
Uncertain
0.019
D
Polyphen
0.65
P
Vest4
0.072
MutPred
0.098
Gain of glycosylation at T1105 (P = 0.1448);
MVP
0.22
MPC
0.50
ClinPred
0.083
T
GERP RS
2.7
Varity_R
0.052
gMVP
0.11

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs759407828; hg19: chrX-107976253; API